Global Biotech Stocks

BioNTech

Market Cap: US$24.5b

A biotechnology company, develops and commercializes immunotherapies to treat cancer and infectious diseases in Germany.

Otsuka Holdings

Market Cap: JP¥3.5t

Engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide.

Celltrion

Market Cap: ₩33.4t

Develops and produces drugs based on proteins for the treatment of oncology in South Korea.

Waters

Market Cap: US$21.5b

Provides analytical workflow solutions in Asia, the Americas, and Europe.

Sandoz Group

Market Cap: CHF 17.4b

Develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide.

Teva Pharmaceutical Industries

Market Cap: US$19.2b

Develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally.

Biogen

Market Cap: US$19.1b

Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases in the United States, Europe, Germany, Asia, and internationally.

Royalty Pharma

Market Cap: US$18.6b

Operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States.

Summit Therapeutics

Market Cap: US$18.1b

A biopharmaceutical company, focuses on discovery, development, and commercialization of patient, physician, caregiver, and societal friendly medicinal therapies.

Zhangzhou Pientzehuang Pharmaceutical

Market Cap: CN¥124.5b

Engages in the manufacture and sale of Chinese medicines under the Pien Tze Huang brand in China and internationally.

Astellas Pharma

Market Cap: JP¥2.5t

Manufactures, markets, and imports and exports pharmaceuticals in Japan and internationally.

West Pharmaceutical Services

Market Cap: US$15.5b

Designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific.

Yunnan Baiyao GroupLtd

Market Cap: CN¥102.1b

Engages in the pharmaceutical business in China, Southeast Asia, Europe, the United States, Japan, and internationally.

Cipla

Market Cap: ₹1.2t

Engages in the manufacture, development, sale, and distribution of pharmaceutical products in India, the United States, South Africa, and internationally.

United Therapeutics

Market Cap: US$14.0b

A biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally.

Shionogi

Market Cap: JP¥2.0t

Engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan.

Illumina

Market Cap: US$13.3b

Provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa.

Genmab

Market Cap: DKK 84.8b

A biotechnology company, develops antibody-based products and product candidates for the treatment of cancer and other diseases in Denmark.

WuXi Biologics (Cayman)

Market Cap: HK$100.3b

An investment holding company, provides end-to-end solutions and services for biologics discovery, development, and manufacturing for biologics industry in the People’s Republic of China, North America, Europe, Singapore, Japan, South Korea, and Australia.

ALTEOGEN

Market Cap: ₩17.4t

A bio company, focuses on developing long-acting biobetters, proprietary antibody-drug conjugates, and antibody biosimilars.

Incyte

Market Cap: US$12.6b

A biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics in the United States, Europe, Canada, and Japan.

Insmed

Market Cap: US$12.5b

Develops and commercializes therapies for patients with serious and rare diseases in the United States, Europe, Japan, and internationally.

Recordati Industria Chimica e Farmaceutica

Market Cap: €10.8b

Researches, develops, produces, and sells pharmaceuticals in Italy, the United States, Spain, France, Germany, Russia, Ukraine, Turkey, Portugal, North Africa, and internationally.

Neurocrine Biosciences

Market Cap: US$12.2b

Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, neuroendocrine, and neuropsychiatric disorders in the United States and internationally.

Exelixis

Market Cap: US$12.1b

An oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States.

Dr. Reddy's Laboratories

Market Cap: ₹1.0t

Operates as an integrated pharmaceutical company worldwide.

Innovent Biologics

Market Cap: HK$92.2b

A biopharmaceutical company, develops, manufactures and commercializes monoclonal antibodies and other drug assets in the fields of oncology, ophthalmology, autoimmune, and cardiovascular and metabolic diseases in China.

Eurofins Scientific

Market Cap: €10.2b

Provides various analytical testing and laboratory services worldwide.

BioMarin Pharmaceutical

Market Cap: US$11.5b

A biotechnology company, engages in the development and commercialization of therapies for life-threatening rare diseases and medical conditions in the United States, Europe, Latin America, the Middle East, the Asia Pacific, and internationally.

Swedish Orphan Biovitrum

Market Cap: SEK 106.5b

A biopharma company, provides medicines in the areas of haematology, immunology, and specialty care in Europe, North America, the Middle East, Asia, and Australia.

Revvity

Market Cap: US$11.0b

Provides health sciences solutions, technologies, and services worldwide.

Exact Sciences

Market Cap: US$10.9b

Provides cancer screening and diagnostic test products in the United States and internationally.

Moderna

Market Cap: US$10.8b

A biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally.

Lupin

Market Cap: ₹911.3b

Operates as a pharmaceutical company in India and internationally.

ICON

Market Cap: US$10.5b

A clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally.

Zydus Lifesciences

Market Cap: ₹895.2b

Engages in the research, development, production, marketing, distribution, and sale of pharmaceutical products in India, the United States, and internationally.